Substance use, self-rated health and HIV status in Brazil

Dados Bibliográficos

ID19444501
AutoresRaquel Brandini De Boni (0000-0002-2455-5997, ICICT, FIOCRUZ, Rio de Janeiro, Brazil, autor correspondente), Mauricio Teixeira Leite De Vasconcellos (0000-0003-1658-2589, Brazilian Institute of Geography and Statistics), Nascimento Silva Pedro Luis (Brazilian Institute of Geography and Statistics), Karollaynne Madonna Louise e Silva (Brazilian Institute of Geography and Statistics), Neilane Bertoni Dos Reis (0000-0002-2539-9965, Brazilian National Cancer Institute, Ministry of Health, Rio de Janeiro, Brazil), Neilane Bertoni, Carolina Coutinho (0000-0002-9005-8171, Fundação Getulio Vargas), Carolina F S Coutinho (Fundação Getulio Vargas), Jurema Correa Mota (0000-0002-5007-1590, ICICT, FIOCRUZ, Rio de Janeiro, Brazil), Francisco I Bastos (0000-0001-5970-8896, ICICT, FIOCRUZ, Rio de Janeiro, Brazil)
Ano2021
Volume33
Fascículo10
Páginas1358-1362
Data de publicação2021-10-03
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoAIDS Care (JOURNAL)
Identificadores do periódicoISSN: 0954-0121 • E-ISSN: 1360-0451
EditoraInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2020.1799923
PMID32741210
OpenAlexW3046368092
IdiomaEN
Citações recebidas3
Referências citadas20

We compared the prevalence of of non-injecting drug use (NIDU) and Self-Rated Health (SRH) among individuals self-reporting as HIV-positive (PLWHA), HIV-negative and unknown at the III Brazilian Household Survey on Substance Use. Overall, 16,273 individuals, 12–65 years old, were interviewed in 2015. Prevalence and Standard Error (SE) were estimated considering the complex sample design and weight calibration. Chi-square tests with Rao-Scott adjustment were used to test independence between NIDU, SRH and HIV status. PLWHA presented higher frequencies of 12-month use for most substances than those reporting to be HIV-negative: alcohol use prevalence was 49.5% (SE 12.8) vs. 43.1% (SE 0.7), p = 0.34; tobacco 45.3% (SE 12.7) vs. 15.3% (SE 0.4), p < 0.01; amphetamines 1.7% (SE 1.7) vs. 0.3% (SE 0.1), p = 0.51; cannabis 10.5%(SE 6.7) vs. 2.5%(0.2), p = 0.06; powder cocaine 3.6% (SE 3.0) vs. 0.9% (SE 0.1), p = 0.45; crack-cocaine 5.3% (SE 3.2) vs. 0.3% (SE 0.1), p < 0.01; inhalants 3.6% (SE 3.0) vs. 0.2% (SE 0), p = 0.03; ketamine 1.7%(SE 1.7) vs. 0.1% (SE 0), p = 0.23; and opioids 1.7% (SE 1.7) vs. 1.4% (SE 0.2), p = 0.93. PLWHA also reported worse SRH. Our results and the scarcity of integrated substance use and HIV treatments call for innovative, cost-effective approaches to tackle these public health challenges

Biology · Cannabis · Intoxicative inhalant · Psychiatry · Substance abuse · Demography · HIV-related health complications and treatments · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Immunology · Toxicology